Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  16,788 results for ""PROSTATE cancer""

Your Filters

Subject : cell proliferation
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Downregulation of hsa_circ_0006620 inhibits the malignant progression of prostate cancer by regulation of the miR-502-3p/HK2 axis mediated by aerobic glycolysis.

  • Authors : Jin M; Shanghai Key Laboratory of Molecular Imaging, Jiading District Central Hospital Affiliated, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.; Wang M

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/genetics ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism

  • Source: Clinical & experimental metastasis [Clin Exp Metastasis] 2024 Dec; Vol. 41 (6), pp. 947-958. Date of Electronic Publication: 2024 Oct 17.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Propofol attenuates prostate cancer progression by upregulating TRHDE-AS1 expression, and METTL14 could mediate its m6A modification.

  • Authors : Chen Z; Department of Anesthesiology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China.; Li Q

Subjects: Propofol*/Propofol*/Propofol*/pharmacology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy

  • Source: Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2024 Nov; Vol. 51 (11), pp. e13924.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0425076 Publication Model: Print Cited Medium: Internet ISSN: 1440-1681

Record details

Read More Add to Saved list
×
Academic Journal

LIMD1-AS1 promotes the progression of prostate cancer and affects the function of prostate cancer cells by down-regulating miR-29c-3p.

  • Authors : Yu Y; Department of Urinary Surgery, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangdong, 511300, China.; He N

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/genetics ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology

  • Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Dec 05; Vol. 151 (1), pp. 5. Date of Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335

Record details

Read More Add to Saved list
×
Academic Journal

CircBIRC6 affects prostate cancer progression by regulating miR-574-5p and DNAJB1.

  • Authors : Zhao B; Department of Urology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.; Yang J

Subjects: Cell Proliferation* ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism

  • Source: Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2399363. Date of Electronic Publication: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8 + T cell activity in prostate cancer.

  • Authors : Liu J; Department of Urology, School of Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China.; Institute of Urinary Oncology, School of Medicine, Tongji University, Shanghai, 200092, China.

Subjects: Tumor Microenvironment*/Tumor Microenvironment*/Tumor Microenvironment*/immunology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/immunology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology

  • Source: Molecular biomedicine [Mol Biomed] 2024 Dec 09; Vol. 5 (1), pp. 67. Date of Electronic Publication: 2024 Dec 09.Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration.

  • Authors : Shao Z; Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510095, China.; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, 511436, Guangdong, China.

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/genetics

  • Source: Cellular & molecular biology letters [Cell Mol Biol Lett] 2024 Dec 02; Vol. 29 (1), pp. 146. Date of Electronic Publication: 2024 Dec 02.Publisher: BioMed Central Country of Publication: England NLM ID: 9607427 Publication Model: Electronic Cited Medium: Internet ISSN: 1689-1392

Record details

Read More Add to Saved list
×
Academic Journal

Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability.

  • Authors : Yu J; State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China; Natural Products Research Center of Guizhou Province, Guiyang 550014, China.

Subjects: Werner Syndrome Helicase*/Werner Syndrome Helicase*/Werner Syndrome Helicase*/metabolism ; Cell Proliferation*/Cell Proliferation*/Cell Proliferation*/drug effects ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy

  • Source: Bioorganic chemistry [Bioorg Chem] 2024 Dec; Vol. 153, pp. 107963. Date of Electronic Publication: 2024 Nov 14.Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Amino polycarboxylic acids-modified abiraterone derivatives as potential injectable anti-prostate cancer agents.

  • Authors : Zhu N; Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, PR China; Center of Drug Safety Evaluation, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, PR China. Electronic address: .

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

  • Source: Bioorganic chemistry [Bioorg Chem] 2024 Dec; Vol. 153, pp. 107824. Date of Electronic Publication: 2024 Sep 14.Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A Dual Action Platinum(IV) Complex with Self-assembly Property Inhibits Prostate Cancer through Mitochondrial Stress Pathway.

  • Authors : Nafees M; Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P.R. China.; Hanif M

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

  • Source: ChemMedChem [ChemMedChem] 2024 Nov 18; Vol. 19 (22), pp. e202400289. Date of Electronic Publication: 2024 Oct 08.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187

Record details

Read More Add to Saved list
×
Academic Journal

HSP90/LSD1 dual inhibitors against prostate cancer as well as patient-derived colorectal organoids.

  • Authors : Tang DW; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.; Chen IC

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 Nov 15; Vol. 278, pp. 116801. Date of Electronic Publication: 2024 Aug 28.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  16,788 results for ""PROSTATE cancer""